Larimar Therapeutics Inc
(LRMR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Operating Expenses | 35,532 | 13,780 | 13,791 | 13,154 | 0 |
| Operating Income | -35,532 | -13,780 | -13,791 | -13,154 | N/A |
| Interest Expense | 870 | 0 | 97 | 0 | 0 |
| Other Income | -76 | -247 | 8 | -3 | 0 |
| Pre-tax Income | -36,478 | -14,027 | -13,880 | -13,157 | 0 |
| Net Income Continuous | -36,478 | -14,027 | -13,880 | -13,157 | N/A |
| Net Income | $-36,478 | $-14,027 | $-13,880 | $-13,157 | $N/A |
| EPS Basic Total Ops | -36.01 | -234.45 | -235.89 | -230.13 | N/A |
| EPS Basic Continuous Ops | -35.93 | -230.99 | -234.69 | -229.24 | N/A |
| EPS Diluted Total Ops | -36.01 | -234.45 | -235.89 | -230.13 | N/A |
| EPS Diluted Continuous Ops | -35.93 | -230.99 | -234.69 | -229.24 | N/A |
| EBITDA(a) | $-35,485 | $-13,768 | $-13,780 | $-13,150 | $N/A |